Related Experiment Video
Updated: Sep 25, 2025

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Implication of COVID-19 in patients of HIV with hepatitis C
1Department of Physiology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India.
Insights
People with HIV and Hepatitis C are at high risk for severe COVID-19. Careful management and public health measures are crucial to prevent fatalities in this immunocompromised population.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Co-infection with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) presents a significant global health challenge.
- Individuals with HIV/HCV co-infection, often immunocompromised, face elevated risks of contracting COVID-19.
- COVID-19 infection in this vulnerable group can lead to severe illness and increased mortality.
Purpose of the Study:
- To review the clinical manifestations of COVID-19 in patients with coexisting HIV and Hepatitis C infection.
- To assess current management strategies for these patients.
- To explore public health measures for mitigating risks associated with COVID-19 in this population.
Main Methods:
- Literature review of existing studies on HIV/HCV co-infected patients with COVID-19.
- Analysis of clinical presentations and outcomes.
- Examination of public health interventions and safety protocols.
Main Results:
- Immunocompromised status in HIV/HCV patients heightens susceptibility to severe COVID-19 outcomes.
- Judicious medical management is essential to prevent exacerbation of their underlying conditions by COVID-19.
- Adherence to safety norms can reduce morbidity and mortality.
Conclusions:
- Public health specialists play a vital role in pandemic management through surveillance, education, and preparedness.
- Effective strategies are needed to protect immunocompromised individuals from severe COVID-19.
- Coordinated medical and public health approaches are necessary for managing COVID-19 in HIV/HCV co-infected populations.
Abstract:
HIV with coexisting Hepatitis C infection has been a global health problem. HIV with Hepatitis C prevalence is significantly higher in people living with HIV. These patients being immunocompromised are at higher risk of contracting COVID-19 infection. Super added COVID-19 infection may prove to be fatal in these patients. We decided to review literature for assessing the clinical manifestations and management of these patients contracting COVID-19 infection and explore the public health measures in practice in the current scenario. Practices of safety norms against COVID-19 shall prevent associated health morbidity and mortality. Moreover, management of these patients needs to be judiciously done by Physicians as COVID-19 infection may worsen their condition. The Public Health Specialist are playing a crucial role in management of COVID-19 pandemic especially by strategy planning for surveillance, health education and preparedness for any future wave of COVID-19 infection.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Causality in Epidemiology
Myocarditis III: Medical Management

